Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.12.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.6 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.56 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.91.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.14 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.485EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.112.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.8 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.440EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.23.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.104 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.17.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.375EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used